CSFZX
Price
$52.43
Change
-$0.14 (-0.27%)
Updated
Dec 17 closing price
RRGTX
Price
$7.19
Change
-$0.02 (-0.28%)
Updated
Dec 17 closing price
Ad is loading...

CSFZX vs RRGTX

Header iconCSFZX vs RRGTX Comparison
Open Charts CSFZX vs RRGTXBanner chart's image
Cohen & Steers Global Realty Z
Price$52.43
Change-$0.14 (-0.27%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc S
Price$7.19
Change-$0.02 (-0.28%)
VolumeN/A
CapitalizationN/A
CSFZX vs RRGTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSFZX vs. RRGTX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSFZX is a Sell and RRGTX is a Hold.

FUNDAMENTALS
Fundamentals
CSFZX has more cash in the bank: 1.92B vs. RRGTX (156M). CSFZX pays higher dividends than RRGTX: CSFZX (2.91) vs RRGTX (1.25). CSFZX was incepted earlier than RRGTX: CSFZX (10 years) vs RRGTX (18 years). RRGTX is a more actively managed with annual turnover of: 82.00 vs. CSFZX (52.00). CSFZX has a lower initial minimum investment than RRGTX: CSFZX (0) vs RRGTX (2500). RRGTX annual gain was more profitable for investors over the last year : 7.60 vs. CSFZX (5.53). CSFZX return over 5 years is better than : 8.58 vs. RRGTX (-5.08).
CSFZXRRGTXCSFZX / RRGTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years18 years-
Gain YTD3.6225.75963%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B156M1,231%
Annual Yield % from dividends2.911.25234%
Returns for 1 year5.537.6073%
Returns for 3 years-10.80-14.5374%
Returns for 5 years8.58-5.08-169%
Returns for 10 years43.0116.42262%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTRX3.740.34
+10.00%
Lantronix
CDLX3.840.07
+1.86%
Cardlytics
EVRG61.500.08
+0.13%
Evergy
PINC21.17-0.59
-2.71%
Premier
MBRX1.86-0.33
-15.07%
Moleculin Biotech